Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

L.A. McKeown

July 24, 2024

News Daily News

JACC Statement Focuses on PAD Disparities, Gaps in Care

L.A. McKeown

December 04, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Daily News

Statins Underprescribed in PAD Before and After Interventions

L.A. McKeown

December 03, 2021

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

News Daily News

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

L.A. McKeown

September 16, 2019

Advertisement

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Platelet Hyperreactivity Score May Improve CVD Risk Detection

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

JACC Statement Focuses on PAD Disparities, Gaps in Care

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Statins Underprescribed in PAD Before and After Interventions

Outcome Differences Between Men and Women With PAD: EUCLID Insights

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content